Northwest Biotherapeutics GmbH

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States and Europe. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines.
 

Details


Adresse:
Northwest Biotherapeutics GmbH

Deutscher Platz 5a
04103 Leipzig
Deutschland
Arbeitsgebiet:
Forschung & Entwicklung
Klinik & Praxis
Sonstige Tätigkeitsfelder
Expansion:
international
Webseite:
Mitarbeiteranzahl:
11-50
Gründungsjahr:
2012